Literature DB >> 4585961

Trimethoprim-sulfamethoxazole in recurrent urinary tract infection in children.

P A Forbes, K N Drummond.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4585961     DOI： 10.1093/infdis/128.supplement_3.s626

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Prophylactic chemotherapy with low-dosage trimethoprim-sulfamethoxazole following acute urinary tract infections in children.

Authors:  N Sher
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

Review 2.  Evaluating the benefits of antimicrobial prophylaxis to prevent urinary tract infections in children: a systematic review.

Authors:  N Le Saux; B Pham; D Moher
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

3.  Normal somatic growth in children receiving low-dose prophylactic co-trimoxazole.

Authors:  J M Smellie; M A Preece; A M Paton
Journal:  Eur J Pediatr       Date:  1983-09       Impact factor: 3.183

Review 4.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

5.  [Immunologic aspects of 2 modes of prevention of urinary tract infection in children with trimethoprim-sulfamethoxazole].

Authors:  J Labbé
Journal:  Can Med Assoc J       Date:  1984-11-15       Impact factor: 8.262
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.